biocartis 产品代理
biocartis 产品代理
Biocartis的专有分子诊断（MDx）IdyllaTM平台是一个完全自动化的样本到结果实时PCR系统，它在几乎任何环境下从几乎任何生物样本中提供准确、高度可靠的分子信息，允许快速有效的治疗选择和治疗进展监测。
Biocartis拥有约500名员工，总部位于比利时梅切伦。
dyllaTM Platform
IdyllaTM Oncology Assays
IdyllaTM Infectious Disease Assays
Biocartis is an innovative molecular diagnostics company committed to revolutionize molecular testing with its unique proprietary IdyllaTM platform. We provide next generation diagnostic solutions, aimed at improving clinical practice for the benefit of patients, clinicians, payers and the healthcare industry, with a focus in oncology which represents the fastest growing segment of the MDx market worldwide. Today, Biocartis offers tests supporting melanoma, colorectal and lung cancer, as well as tests for SARS-CoV-2 and sepsis.
Biocartis’ proprietary molecular diagnostics (MDx) IdyllaTM platform is a fully automated sample-to-result, real-time PCR system that offers accurate, highly reliable molecular information from virtually any biological sample, in virtually any setting, allowing fast and effective treatment selection and treatment progress monitoring.
Biocartis employs approx. 500 people and is headquartered in Mechelen, Belgium.
